Skip to main content

Advertisement

SpringerLink
Log in

Uterine sarcoma 2008

  • Published:
Current Oncology Reports Aims and scope Submit manuscript

Abstract

Uterine sarcomas are a group of rare and usually aggressive soft tissue cancers. They have a wide range of histologic appearances, from myomatous to osteous to stromal. The three major subtypes of uterine sarcomas (listed in decreasing order of incidence) are carcinosarcoma, leiomyosarcoma, and endometrial stromal sarcoma. Most patients with uterine sarcomas are middle-to older-aged women who present with abnormal uterine bleeding or pelvic mass, which may be confused with leiomyoma. Surgery—including hysterectomy and resection of disease—serves as the main treatment modality. Adjuvant therapies, including radiation, chemotherapy, and/or hormonal therapy, have limited benefit on overall survival; however, this may be due to the lack of good randomized controlled trials of sufficient size because of uterine sarcomas’ rare and aggressive nature. For patients with metastatic recurrent disease, aggressive therapy is limited by low response rates and limited duration of response. For patients with uterine sarcomas, enrollment in clinical trials is strongly encouraged.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Brooks S, Zhan M, Cote T: Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989–1999. Gynecol Oncol 2004, 93:204–208.

    Article  PubMed  Google Scholar 

  2. Platz CE, Benda JA: Female genital tract cancer. Cancer 1995, 75(1 Suppl):270–294.

    Article  Google Scholar 

  3. McMeekin D: Sarcoma of the Uterus. In: Clinical Gynecologic Oncology, end 7. Edited by DiSaia P, Creasman W. Philadelphia: Elsevier; 2007:185–199.

    Google Scholar 

  4. Silverberg S, Kurman R: Tumors of the uterine corpus and gestational trophoblastic disease. In: Atlas of Tumor Pathology. Edited by Rosai J, Sobin LH. Washington DC: Armed Forces Institute of Pathology; 1992.

    Google Scholar 

  5. Bansal N, Herzog T, Burke W, et al.: The utility of preoperative endometrial sampling for the detection of uterine sarcomas. Gynecol Oncol 2008, 110:43–48.

    Article  PubMed  Google Scholar 

  6. Memarzadeh S, Mundt A, Berek J: Classification, clinical manifestations, and staging of uterine sarcoma. Available at http://www.uptodate.com/patients/cotent/topic.do?topicKey=:_Md99fpsgNAsSR0. Accessed August 2008.

  7. Ferrer F, Sabater S, Farrus B, et al.: Impact of radiotherapy on local control and survival in uterine sarcomas: a retrospective study from the Grup Oncologic Catala-Occita. Int J Radiat Oncol Biol Phys 1999, 44:47–52.

    Article  PubMed  CAS  Google Scholar 

  8. Hornback NB, Omura G, Major FJ: Observations on the use of adjuvant radiation therapy in patients with stage I and II uterine sarcoma. Int J Radiat Oncol Biol Phys 1986, 12:2127–2130.

    PubMed  CAS  Google Scholar 

  9. Knocke TH, Kucera H, Dorfler D, et al.: Results of postoperative radiotherapy in the treatment of sarcoma of the corpus uteri. Cancer 1998, 83:1972–1979.

    Article  PubMed  CAS  Google Scholar 

  10. Molpus K, Redlin-Frazier S, Reed G, et al.: Postoperative pelvic irradiation in early stage uterine mixed mullerian tumors. Eur J Gynaecol Oncol 1998, 19:541–546.

    PubMed  CAS  Google Scholar 

  11. Moskovic E, MacSweeney E, Law M, Price A: Survival, patterns of spread and prognostic factors in uterine sarcoma: a study of 76 patients. Br J Radiol 1993, 66:1009–1015.

    PubMed  CAS  Google Scholar 

  12. Reed NS, Mangioni C, Malmstrom H, et al.: First results of a randomized trial comparing radiotherapy versus observation postoperatively in patients with uterine sarcomas. An EORTC-GCG Study [abstract]. Int J Gynecol Cancer 2003, 13(Suppl 11):4.

    Google Scholar 

  13. Salazar O, Bonfiglio T, Patten S, et al.: Uterine sarcomas: analysis of failures with special emphasis on the use of adjuvant radiation therapy. Cancer 1978, 42:1161–1170.

    Article  PubMed  CAS  Google Scholar 

  14. Soumarova R, Horova H, Seneklova Z, et al.: Treatment of uterine sarcoma. A survey of 49 patients. Arch Gynecol Obstet 2002, 266:92–95.

    Article  PubMed  CAS  Google Scholar 

  15. Weitmann H, Knocke TH, Kucera H, Potter R: Radiation therapy in the treatment of endometrial stromal sarcoma. Int J Radiat Oncol Biol Phys 2001, 49:739–748.

    PubMed  CAS  Google Scholar 

  16. Kempson R, Bari W: Uterine sarcomas: classification, diagnosis and prognosis. Hum Pathol 1970, 1:331–349.

    Article  PubMed  CAS  Google Scholar 

  17. DiSaia PJ, Pecorelli S: Gynecological sarcomas. Semin Surg Oncol 1995, 10:369–373.

    Article  Google Scholar 

  18. Kahanpaa KV, Wahlstrom T, Grohn P, et al.: Sarcomas of the uterus: a clinicopathologic study of 119 patients. Obstet Gynecol 1986, 67:417–424.

    PubMed  CAS  Google Scholar 

  19. Sherman ME, Devesa SS: Analysis of racial differences in incidence, survival and mortality for malignant tumors of the uterine corpus. Cancer 2003, 98:176–186.

    Article  PubMed  Google Scholar 

  20. Gorai I, Yanagibashi T, Taki A, et al.: Uterine carcinosarcoma is derived from a single stem cell: an in vitro study. Int J Cancer 1997, 72:821–827.

    Article  PubMed  CAS  Google Scholar 

  21. Zelmanowicz A, Hildesheim A, Sherman ME, et al.: Evidence for a common etiology for endometrial carcinomas and malignant mixed mullerian tumors. Gynecol Oncol 1998, 69:253–257.

    Article  PubMed  CAS  Google Scholar 

  22. Sartori E, Bazzurini L, Gadducci A, et al.: Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study. Gynecol Oncol 1997, 67:70–75.

    Article  PubMed  CAS  Google Scholar 

  23. Greer B, Koh W, Abu-Rustum N, et al.: Uterine Neoplasms. Available at http://www.nccn.org/professionals/physician_gls/PDF/uterine.pdf. Accessed August 2008.

  24. Hoskins P, Le N: Preoperative tumor markers at diagnosis in women with malignant mixed müllerian tumors/carcinosarcoma of the uterus. Int J Gynecol Cancer 2008 (Epub ahead of print).

  25. Huang GS, Chiu LG, Gebb JS, et al.: Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcoma. Gynecol Oncol 2007, 107:513–517.

    Article  PubMed  CAS  Google Scholar 

  26. Gerszten K, Faul C, Kounelis S, et al.: The impact of adjuvant radiotherapy on carcinosarcoma of the uterus. Gynecol Oncol 1998, 68:8–13.

    Article  PubMed  CAS  Google Scholar 

  27. Omura GA, Blessing JA, Major F: A randomized clinical trial of adjuvant adriamycin in uterine sarcoma: a Gynecologic Oncology Group Study. J Clin Oncol 1985, 3:1240–1245.

    PubMed  CAS  Google Scholar 

  28. Resnik E, Chambers S, Carcangiu M: A phase II study of etoposide, cisplatin and doxorubicin chemotherapy in mixed mullerian tumors (MMT) of the uterus. Gynecol Oncol 1995, 56:370–375.

    Article  PubMed  CAS  Google Scholar 

  29. Homesley HD, Filiaci V, Markman M, et al.: Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group Study. J Clin Oncol 2007, 25:526–531.

    Article  PubMed  CAS  Google Scholar 

  30. O’Connor D, Norris H: Mitotically active leiomyomas of the uterus. Hum Pathol 1990, 21:223–227.

    Article  PubMed  CAS  Google Scholar 

  31. Bell SW, Kempson RL, Hendrickson MR: Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol 1994, 18:535–558.

    Article  PubMed  CAS  Google Scholar 

  32. Evans HL, Chawla SP, Simpson C, Finn KP: Smooth muscle neoplasms of the uterus other than ordinary leiomyoma. A study of 46 cases, with emphasis on diagnostic criteria and prognostic factors. Cancer 1988, 62:2239–2247.

    Article  PubMed  CAS  Google Scholar 

  33. Parker W, Fu Y, Berek J: Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstet Gynecol 1994, 83:414–418.

    PubMed  CAS  Google Scholar 

  34. Juang CM, Yen MS, Horng HC, et al.: Potential role of preoperative serum CA125 for the differential diagnosis between uterine leiomyoma and uterine leiomyosarcoma. Eur J Gynaecol Oncol 2006, 27:370–374.

    PubMed  CAS  Google Scholar 

  35. Gadducci A, Landoni F, Sartori E: Uterine leiomyosarcoma: analysis of treatment failures and survival. Gynecol Oncol 1996, 62:25–32.

    Article  PubMed  CAS  Google Scholar 

  36. Peters W, Howard D, Andersen W, Figge D: Uterine smooth-muscle tumors of uncertain malignant potential. Obstet Gynecol 1994, 83:1015–1020.

    Article  PubMed  Google Scholar 

  37. Kapp D, Shin J, Chan J: Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy. Cancer 2008, 112:820–830.

    Article  PubMed  Google Scholar 

  38. Fleming G: Gemcitabine/docetaxel—welcome to a new standard. Gynecol Oncol 2008, 109:313–315.

    Article  PubMed  Google Scholar 

  39. Hensley ML, Blessing JA, Degeest K, et al.: Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study. Gynecol Oncol 2008, 109:323–328.

    Article  PubMed  CAS  Google Scholar 

  40. Hensley ML, Blessing JA, Mannel R, Rose PG: Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial. Gynecologic Oncology 2008, 109:329–334.

    Article  PubMed  CAS  Google Scholar 

  41. Leath C, Huh W, Hyde J, et al.: A multi-institutional review of outcomes of endometrial stromal sarcoma. Gynecol Oncol 2007, 105:630–634.

    Article  PubMed  Google Scholar 

  42. Evans HL: Endometrial stromal sarcoma and poorly differentiated endometrial sarcoma. Cancer 1982, 50:2170–2182.

    Article  PubMed  CAS  Google Scholar 

  43. Oliva E, Clement P, Young R: Endometrial stromal tumors: an update on a group of tumors with a protean phenotype. Adv Anat Pathol 2000, 7:257–281.

    Article  PubMed  CAS  Google Scholar 

  44. Gadducci A, Sartori E, Landoni F, et al.: Endometrial stromal sarcoma: analysis of treatment failures and survival. Gynecol Oncol 1996, 63:247–253.

    Article  PubMed  CAS  Google Scholar 

  45. Verschraegen C, Vasuratna A, Edwards C, et al.: Clinicopathologic analysis of mullerian adenosarcoma: the M.D. Anderson Cancer Center experience. Oncol Rep 1998, 5:939–944.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Women’s Cancer Center, Morristown Memorial Hospital, 100 Madison Avenue, Morristown, NJ, 07962, USA

    Brian M. Slomovitz

Authors
  1. Jeff F. Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Brian M. Slomovitz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Brian M. Slomovitz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lin, J.F., Slomovitz, B.M. Uterine sarcoma 2008. Curr Oncol Rep 10, 512–518 (2008). https://doi.org/10.1007/s11912-008-0077-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11912-008-0077-9

Keywords

Search

Navigation